Key result
Directional coronary atherectomy plus stenting and LIMA-LAD yielded similar long-term MACE rates (4.6 vs 3.0 per 100 person-years) for isolated proximal LAD lesions, with 79% vs 89% MACE-free at 5 years.
Why the study?
Does directional coronary atherectomy plus stent implantation improve clinical outcomes compared to left internal mammary artery bypass grafting in patients with isolated proximal LAD lesions?
Cohort (n=258)
Does directional coronary atherectomy plus stent implantation improve clinical outcomes compared to left internal mammary artery bypass grafting in patients with isolated proximal LAD lesions?
DCA plus stenting and LIMA-LAD both provide good long-term outcomes for isolated proximal LAD disease, with DCA/stenting having fewer periprocedural events but higher rates of target vessel revascularization.
Answers are grounded in this paper and cite their sources.
Both approaches offer durable results in proximal LAD disease; leaves open optimal selection pending randomized trials.
The aim of this study was to compare the short- (< 30 days) and long-term (> or = 30 days) clinical outcomes of left internal mammary artery bypass grafting (LIMA-LAD) and directional coronary atherectomy plus stent implantation (DCA + stent) in the treatment of isolated proximal left anterior descending coronary (LAD) lesions. One hundred and twenty-six patients underwent LIMA-LAD and 132 consecutive patients underwent DCA + stenting. The primary endpoint was the incidence of short- and long-term major adverse cardiac events (MACE); the secondary endpoints included any periprocedural events and long-term target vessel revascularization (TVR). We found no significant between-treatment difference in the occurrence of short-term MACE, and the long-term MACE rate per 100 person-years was 3.0 in the LIMA-LAD group and 4.6 in the DCA + stent group. After 5-year follow-up, 79% of the patients in the DCA + stent group and 89% of those in the LIMA-LAD group were still MACE-free. The risk of any periprocedural events was six times lower in the DCA + stent group, and the risk of TVR was six times higher. We conclude that both procedures lead to good short- and long-term follow-up results in isolated proximal LAD disease. As fewer periprocedural events and more TVRs occur after DCA + stenting than after LIMA-LAD, they can be considered valuable alternatives to each other.
No takes yet. Share an insight, caveat, or question.
Brambilla et al. (2004) conducted a cohort in isolated proximal stenosis of the left anterior descending coronary artery (n=258). Directional coronary atherectomy plus stent implantation (DCA + stent) vs. Left internal mammary artery bypass grafting (LIMA-LAD) was evaluated on Incidence of short- (< 30 days) and long-term (>= 30 days) major adverse cardiac events (MACE). Directional coronary atherectomy plus stenting and LIMA-LAD yielded similar long-term MACE rates (4.6 vs 3.0 per 100 person-years) for isolated proximal LAD lesions, with 79% vs 89% MACE-free at 5 years.
Synapse has enriched 10 related papers. Consider them for comparative context: